Role Summary
As the US Pet Health Vet Launch Manager, you will lead project management activities to ensure successful, on-time launches of veterinary products. In this role, you will partner closely with the US Pet Health Vet Launch Managers, and cross-functional stakeholders to design robust launch plans, proactively manage risk, and ensure alignment with Elanco Launch Excellence standards. Your work will directly enable the delivery of high-quality products to customers at launch.
Responsibilities
- Independently lead project management activities for prioritized US Pet Health launch initiatives to ensure launch readiness
- Partner with cross-functional teams including Marketing, Regulatory, Manufacturing, Quality, R&D, Finance, New Product Planning, Innovation Strategy, and Affiliate Commercial teams to develop and maintain integrated launch plans
- Define, manage, and communicate launch scope, milestones, deliverables, and timelines using approved project management tools
- Identify and actively manage critical path activities, risks, and leading indicators impacting launch milestones
- Monitor performance to plan, escalate issues as needed, and drive corrective actions in partnership with the US Launch Excellence Lead
- Develop and maintain detailed launch timelines and process maps, ensuring alignment across functions
- Proactively manage schedule updates and communicate changes to stakeholders
- Partner with Brand Managers to support launch budget planning, forecasting, and re-forecasting
- Provide leadership with clear visibility into cost implications of launch scenarios and variances
- Lead launch risk assessments, mitigation strategies, and contingency planning, with clear ownership and escalation
- Proactively identify risks impacting launch timelines or portfolio milestones and take action to mitigate or avoid delays
- Apply a strong quality mindset across all project activities and escalate issues appropriately
- Ensure accurate documentation of decisions, scope changes, metrics, and launch readiness indicators
- Coordinate launch governance, including meeting logistics, agendas, documentation, and minutes
- Influence cross-functional teams to operate with a consistent quality and execution mindset
- Assess resource constraints and capacity risks, providing recommendations on scope, budget, and resourcing impacts
- Drive continuous improvement by identifying, sharing, and embedding best practices across launch and project management teams
- Lead and participate in retrospective reviews to capture lessons learned and improve future launch execution
Qualifications
- Required: Bachelorβs degree in Life Sciences, Pharmacy, Biotechnology, Engineering, Business, or equivalent
- Required: Minimum of 5 years of experience in the pharmaceutical or biotechnology industry, with direct involvement in product launch, commercialization, or new product introduction
- Required: Proven experience managing cross-functional projects in a matrixed environment
- Required: Strong project management capabilities including timeline development, milestone tracking, risk mitigation, and budget oversight
- Required: Excellent written and verbal communication skills with the ability to influence diverse stakeholders
- Preferred: Strategic mindset with the ability to translate market insights into actionable launch plans
- Preferred: Strong analytical skills, including interpretation of market, sales, and forecast data
- Preferred: Experience with end-to-end launch readiness, from pre-launch planning through operational execution
- Preferred: High level of stakeholder management across Commercial, Supply, Regulatory, Medical, and other functions
- Preferred: Comfort leading through ambiguity in fast-paced, evolving environments
- Preferred: Digital fluency with project management tools, dashboards, and forecasting models
- Preferred: Demonstrated ability to lead, motivate, and influence teams without direct authority
Additional Requirements
- Location: Global Elanco Headquarters, Indianapolis, IN β Hybrid work environment
- Travel: less than 10% of time.